Combination Chemo Helps People with Leiomyosarcoma Live Longer
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
On Sept. 14, 2008, the National Cancer Institute (NCI) researchers and colleagues have shown that increased expression of…
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
On Mar. 4, 1991, researchers reported that post-operative (adjuvant) radiation therapy and chemotherapy were found to improve survival…
In 1953, Yale established the first pharmacology department in the U.S. to focus on cancer chemotherapy and cancer…
On Aug. 27, 1942, chemotherapy was first used to treat a cancer patient and the beginning of its…